Waverley Pharma Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported net loss was CAD 0.264126 million compared to CAD 0.339558 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.015 CAD | 0.00% | 0.00% | -40.00% |
Jun. 20 | Waverley Pharma Inc. Elects James Kinley as Director | CI |
May. 29 | Waverley Pharma Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
1st Jan change | Capi. | |
---|---|---|
-40.00% | 595K | |
+20.95% | 127B | |
+23.00% | 117B | |
+25.88% | 27.77B | |
-19.75% | 20.44B | |
-14.92% | 16.62B | |
-16.56% | 15.92B | |
+11.19% | 14.74B | |
-46.65% | 14.94B | |
+57.74% | 14.38B |
- Stock Market
- Equities
- WAVE Stock
- News Waverley Pharma Inc.
- Waverley Pharma Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024